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SINCE Zollinger (1953) and Tonz (1957) described the induction of kidney
tumours in rats by the repeated parenteral injection of lead phosphate, investiga-
tions have been carried out to confirm these findings. Boyland, Dukes, Grover
and Mitchley (1962) reported the induction of renal tumours in rats fed a diet
containing 1F0 per cent lead acetate. In this experiment 15 out of 26 rats devel-
oped kidney tumours. Van Esch, Van Genderen and Vink (1962) found renal
neoplasms in 13 out of 24 rats given 1 0 per cent lead acetate, and in 11 out of 32
rats given 01 per cent of basic lead acetate. The purpose of the experiments
described in this paper was to investigate whether basic lead acetate would also
induce tumours in mice and hamsters.
EXPERIMENTAL
Material and Method
Mice
In this experiment a control group and 2 experimental groups, each consisting
of 50 Swiss mice, were used. Each group consisted of an equal number of male
and female animals littermate distributed. The 5-week old mice (weight 15-20 g.)
were obtained from the Swiss colony of our Institute.
The animals were housed in plastic cages, in groups of 10, and fed a powdered
standard diet consisting of two thirds whole wheat flour and one third whole
milk powder with addition of a salt mixture of 0 5 per cent sodium chloride and
0 5 per cent calcium carbonate. Food and tap water were given ad libitum. The
experimental groups received basic lead acetate (crystalline, Merck Darmstadt)
mixed into the standard diet in the following dosages:
Group 1 control: 0 per cent basic lead acetate.
Group 2 : 0-1 per cent basic lead acetate.
Group 3 : I 0 per cent basic lead acetate. This dose level was decreased
to 0 5 per cent for the male animals 92 days and for the
female animals 114 days after the beginning of the basic
lead acetate administration.
Four days before the beginning of the experiment the mice were vaccinated
against ectromelia with a variola vaccine (1 : 100) 0-1 ml. per animal. The dura-
tion ofthe experiment was 2 years. Moribund animals were killed and examined
macroscopically and microscopically. The same was done with the remaining
animals at the end ofthe experiment.G. J. VAN ESCH AND R. KROES
Hamsters
In this experiment three groups of 45 or 46 golden hamsters (from the Centraal
Proefdieren Bedrijf T.N.O., Zeist) were used. In these groups the female and
male animals were littermate distributed. In the control group there were 23
females and 22 males, in the experimental groups 24 females and 22 males. The
age of the hamsters at the beginning of the experiment was 3 to 4 weeks and the
average weight 40-60 g. The animals were housed in wire cages, in each cage 3
animals according to sex. The diet consisted of equal parts of Cavicon® and
Muracong (from the Institute for Scientific Research in the field of Animal
Nutrition, Putten, The Netherlands).
The dose levels of basic lead acetate in the experiment with hamsters were
chosen after a preliminary range-finding experiment. The animals ofthe different
groups received the following dose levels in their diet:
Group 4: 0 per cent basic lead acetate.
Group 5: 0-1 per cent basic lead acetate.
Group 6: 0 5 per cent basic lead acetate.
The duration of the experiment was 2 years. Animals which died and the
animals which were killed at the end of the experiment were examined in the
same way as the mice.
In both experiments gross histopathological examination was carried out and
liver and kidneys of all animals, and in addition all organs and tissues which
macroscopically showed abnormalities, were examined microscopically.
The material was fixed in 4 per cent formalin and paraffin sections were cut at
5 ,u and stained with haemalum and eosin.
In some cases special stains for glycogen, mucopolysaccharides, reticulum,
collagen and amyloid were used.
Results of the Experiments
Mice
The mortality was recorded and it was found that many animals fed with 1P0
per cent ofbasic lead acetate, had died already early in the experiment. For this
reason the dose level of 1.0 per cent was decreased to 0 5 per cent. In the group
with 0.1 per cent no obvious difference in mortality in comparison with the control
group was found (Fig. 1).
Incidence of tumours in the mice.-The incidence of the tumours of all groups
is given in Table I. It is clear from these findings that lung adenomas, adenomas
and adenocarcinomas of the mammae, tumours of the dermis and lymphatic
leukaemia, develop spontaneously in the strain of mice used in this experiment.
In the control animals no renal tumours were found. In the females ofthe 0'1 per
cent basic lead acetate group one renal adenoma andin the males, 2 renal adenomas
and 4 renal carcinomas, from which one had a clear cell appearance, were induced.
In the 1.0/0.5 per cent group in one female animal a renal carcinoma was found.
The appearance of only one renal tumour in the 1-0/0.5 per cent group can be
explained by the fact that in this group most animals died before tumours could
be induced. Obviously this concentration of basic lead acetate was too toxic.
The renal tumours classified as adenoma, were single or multiple tumours
which were poorly encapsulated. They consisted of monomorphic cells with
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FIG. 1.-Survival curves ofmice. Controls; - - - - 0.1 per cent basic lead acetate;
-* * 1-0/0-5 per cent basic lead acetate.
TABLE I.-Incidence ofTumours in the Mice
Type of tumours
Lungs:
adenoma
metastatic carcinoma
of mamma
Liver:
hepatoma
Kidneys:
adenoma
carcinoma
clear cell carcinoma
Mamma:
adenoma
adenocarcinoma
Lymphopoietic system:
lymphatic leukaemia
Dermis:
epidermoid cyst
haemangio-endothelioma
0-1 per cent 0-1/0-5 per cent
Control group basic lead acetate basic lead acetate
Females Males Females Males Females Males
3 3 . 5
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eosinophilic cytoplasm and monomorphic nuclei with a normal chromatine
pattern. The adenomas had an adenomatous aspect and in one adenoma micro-
villi could be found. Because of this latter finding and the morphological simi-
larity of all the adenomas it seems that these adenomas are developed from the
proximal tubules. In this case it is interesting that Mao and Molnar (1967)
observed in an ultrastructural study of lead induced renal tumours in rats, that
the apical surfaces of tumour cells were equipped with microvilli. Four tumours
showed cells with eosinophilic cytoplasm and extreme cellular and nuclear poly-
morphism. Occasionally mitoses were found, and sometimes an indication of
infiltration of tumour cells in the adjacent tissue could be observed. Partial
encapsulation was present.
For these reasons these tumours were called carcinomas (Fig. 2). No metastases
could be found. One " clear cell " carcinoma was found (Fig. 3). This tumour
was morphologically identical to the " clear cell " carcinomas which are found in
man (Lucke and Schlumberger, 1957; Evans, 1966).
Other aspects of renal damage.-In the kidneys several other abnormalities due
to the administration of basic lead acetate were present. Although metaplasia
of the epithelium of Bowman's capsule is also common in the control mice, we
found this abnormality more pronounced in the basic lead acetate groups. In
this case the epithelium was much higher and almost all capsules were showing
this metaplasia, while in the control animals metaplasia was seen in part of the
capsules only. Enlarged nuclei were found very often, mostly in the proximal
tubules but also in the distal tubules, however, to a lesser degree. This abnor-
mality increases with the dose level. Acidophilic intranuclear inclusions were
found in the same tubules. In many cases cysts were found, coveredwith irregular
epithelium with cellular and nuclear polymorphism, which was sometimes multi-
stratified. The cells had fine granular eosinophilic cytoplasm. Some cysts were
covered with normal, flattened epithelium, but this was found in the control
animals too. The cysts seemed to be similar to those described by Finner and
Calvary (1939) and Tonz (1957). In the 1-0/0-5 per cent dose group some dark
brown concrements were found, which showed lamination. It is suggested that
these could be lead deposits according to Tonz (1957). The nuclear alterations
and intranuclear inclusions were similar to those described by Finner and Calvary
(1939), Tonz (1957) and Richter, Kress and Cornwall (1968).
Otherhistopathologicalfindings in the mice.-As mentioned before, many animals
died during the experiment, especially in the 1-0/0-5 per cent basic lead acetate
group. Many of these animals died overnight and showed extensive autolysis
on post-mortem examination.
Abnormalities found in the heart, lungs, pleura, spleen, ovaries, mammae,
urinary bladder and dermis are common for this strain of mice. The glandular
hyperplasia of the uterus, only found in 5 of the 25 females of the 0-1 per cent
group, is possibly due to the administration of basic lead acetate. Typical
acidophilic intranuclear inclusions which were found in the livers of 5 animals
EXPLANATION OF PLATE
FIG. 2. Carcinoma in the cortex ofthe kidney: cellular and nuclear polymorphism. Mouse
with 0.1 per cent lead acetate in the diet.
FIG. 3.-Clear cell carcinoma in the cortex of the kidney. Mouse with 0.1 per cent lead
acetate in the diet.
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ofgroup 2 and 8 animals ofgroup 3 are thought to be induced by the administra-
tion of basic lead acetate. These inclusions were different from the inclusions
normally seen in the liver nuclei of mice. They were more acidophilic, circum-
script and had in some cases rectangular forms. In one female animal of the
0 1 per cent group a hepatoma was found.
Male mice appeared to be more sensitive to the basic lead acetate than females.
Hamsters
In the group with 0 1 per cent basic lead acetateaslightincreaseinthe mortality
was found. In the highest dose level this increase in mortality was clear. In
this case the main part of the animals died within the first year (Fig. 4).
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FIG. 4. Survival curves of hamsters. Controls; --- 0- O1 per cent basic lead
acetate; . 0- 5 per cent basic lead acetate.
Incidence of tumours in the hamster.-The tumours and hyperplasias which
were found in this experiment are given in Table II.
In the experiment with hamsters no renal tumours or early stage of tumour
growth was found.
Other aspects ofrenal damage.-Besides the alterations mentioned above typical
abnormalities due to the administration of basic lead acetate were found. The
alterations were most pronounced in the kidneys. Most animals showed pleo-
morphic cells with hypertrophic nuclei in their kidneys in the juxtamedullar
proximal tubulus. Intranuclear inclusions were very common. These alterations
were similar to those described by Finner and Calvery (1939), Pardoe (1952),
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TABLE II.-Incidence of Tumours and Hyperplasias in the Hamsters
0-1 per cent 0 5 per cent
Control basic lead acetate basic lead acetate
Type of tumours Females Males Females Males Females Males
Adenoma ofbronchial glands . 1
Bileduct proliferation: cyst-adenomatous . 13 11 6 6 . 2 4
adenomatous . 1 2 . 3 3 2 1
" ovalcelltype" 2 2 4 3
Thyroidhyperplastic nodules 2 3 2
Adenoma ofadrenal cortex . 1
Cystic hyperplasia ofthe crypts in duodenum. - 1 1
Lymphopoeitic system: lymphatic leukaemia
(lymphoblastic) . 1
Multiple myeloma . 1 . 1
Tonz (1957) and Richter, Kress and Cornwall (1968). The alterations which were
first seen only in the juxtamedullary region, were found too in the cortex especially
in the group with the highest dose level. In the animals, which died early in the
experiment, a typical degeneration of the proximal tubules was found. The
tubule cells were swollen and showed apically many round vacuoles. Some
nuclei showed severe pycnosis. Henle's loops and the distal tubules showed a
marked degeneration with loss ofcell boundaries, karyopycnosis and desquamation
of necrotic cells. In the animals, which received basic lead acetate for a longer
time, intra- and inter-tubular concrements, perhaps lead salt concrements (Tonz,
1957), were found in the cortex. These concrements contained calcium too, as
was seen with Kossa's stain.
Other histopathological findings in the hamsters. In this study many abnor-
malities were found which are common in our hamster strain. One of these
abnormalities is an amyloidosis of the liver, kidneys and spleen and sometimes
other organs. The severity of the amyloidosis increases with age. It was found
that in the animals which received basic lead acetate amyloidosis was not as
severe as in the controls. The reason for this was that the animals, which received
basic lead acetate, died much earlier than the control animals. For the same
reason bile duct proliferation was most pronounced in the control animals. The
" oval cell type " bile duct proliferation could be due to the administration of
basic lead acetate because we did not find this proliferation in the control animals.
The thyroid hyperplasia which was observed may be related to the age of the
animals.
DISCUSSION
The purpose of this study was to investigate the carcinogenic effect of basic
lead acetate in mice and hamsters.
In the mice, which were fed basic lead acetate, renal tumours were induced.
In the hamsters, however, no tumours were found.
The tumours found in the mice were classified as adenoma or carcinoma accor-
ding to their morphological appearance. No metastases were found. In the
mouse and hamster strain that was used spontaneous renal tumours were never
found. The pathological changes found in the kidneys of the mice and hamsters
were similar to those which are described for rats by Finner and Calvery (1939);
Pardoe (1952); Tonz (1957) and Richter, Kress and Cornwall (1968).INDUCTION OF RENAL TUMOURS BY LEAD ACETATE 771
The results of the experiments mentioned in this report show that basic lead
acetate is carcinogenic to mice. Because of the high susceptibility of hamsters
to the toxic effect of basic lead acetate this effect could not be demonstrated
in this experiment.
The other abnormalities found in mice and hamsters were not different
from those described for rats (Boyland, Dukes, Grover and Mitchley, 1962; Van
Esch, Van Genderen and Vink, 1962) and in view ofthe fact that in rats and mice
besides these abnormalities renal tumours were induced, it may be suspected that
basic lead acetate is possibly also carcinogenic to hamsters.
SUMMARY
Chronic experiments with mice and hamsters were carried out to study whether
basic lead acetate would be carcinogenic to these animals.
Basic lead acetate was given to mice in a dose level of 0-1 and 1.0/0.5 per cent
and to hamsters in a dose level of 0.1 and 0 5 per cent in the diet.
In mice in the 0.1 per cent group 7 renal tumours were found in 50 animals.
in the 1.0/0.5 per cent group only 1 renal tumour was found.
Most mice ofthe 1-0/0.5 per cent group and hamsters ofthe 0 5 per cent group
died early in the experiment, because of an intoxication by the basic lead acetate.
In hamsters no tumours ofthe kidneys could be found.
Other specific alterations ofthe kidney (these changes could be ascribed to the
basic lead acetate) were foundin both animal species.
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